You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

List of Excipients in API cinacalcet


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing cinacalcet

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
A-S Medication Solutions SENSIPAR cinacalcet hydrochloride 50090-3529 CARNAUBA WAX
A-S Medication Solutions SENSIPAR cinacalcet hydrochloride 50090-3529 CELLULOSE, MICROCRYSTALLINE
A-S Medication Solutions SENSIPAR cinacalcet hydrochloride 50090-3529 CROSPOVIDONE
A-S Medication Solutions SENSIPAR cinacalcet hydrochloride 50090-3529 MAGNESIUM STEARATE
A-S Medication Solutions SENSIPAR cinacalcet hydrochloride 50090-3529 POVIDONE
A-S Medication Solutions SENSIPAR cinacalcet hydrochloride 50090-3529 SILICON DIOXIDE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Excipients in ANDA-approved (generic) drugs containing cinacalcet

Company Ingredient NDC Excipient
Mylan Pharmaceuticals Inc cinacalcet 0378-6197 CELLULOSE, MICROCRYSTALLINE
Mylan Pharmaceuticals Inc cinacalcet 0378-6197 CROSPOVIDONE
Mylan Pharmaceuticals Inc cinacalcet 0378-6197 FD&C BLUE NO. 2
Mylan Pharmaceuticals Inc cinacalcet 0378-6197 FERRIC OXIDE YELLOW
Mylan Pharmaceuticals Inc cinacalcet 0378-6197 HYPROMELLOSE
Mylan Pharmaceuticals Inc cinacalcet 0378-6197 MAGNESIUM STEARATE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for cinacalcet

Excipient focus: CARNAUBA WAX

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CROSPOVIDONE

Excipient focus: D&C YELLOW NO. 10

Excipient focus: FD&C BLUE NO. 2

cinacalcet drug variants not containing FD&C BLUE NO. 2

Company Ingredient NDC
Zydus Pharmaceuticals (USA) Inc cinacalcet 70710-1000
Cadila Healthcare Limited cinacalcet 70771-1054
A-S Medication Solutions cinacalcet hydrochloride 50090-3529
A-S Medication Solutions cinacalcet hydrochloride 50090-4470
A-S Medication Solutions cinacalcet hydrochloride 50090-7096
State of Florida DOH Central Pharmacy cinacalcet hydrochloride 53808-0577
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2208

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MANNITOL

Excipient focus: MICROCRYSTALLINE CELLULOSE 102

Excipient focus: POLOXAMER 407

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOL 6000

Excipient focus: POLYETHYLENE GLYCOLS

Excipient focus: POLYVINYL ALCOHOL

Excipient focus: POVIDONE

Excipient focus: POVIDONE K30

Excipient focus: POVIDONES

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM STEARYL FUMARATE

Excipient focus: STARCH, CORN

Excipient focus: STARCH, PREGELATINIZED CORN

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

cinacalcet drug variants not containing TITANIUM DIOXIDE

Company Ingredient NDC
A-S Medication Solutions cinacalcet hydrochloride 50090-3529
A-S Medication Solutions cinacalcet hydrochloride 50090-4470
A-S Medication Solutions cinacalcet hydrochloride 50090-7096
State of Florida DOH Central Pharmacy cinacalcet hydrochloride 53808-0577
Physicians Total Care Inc cinacalcet hydrochloride 54868-5616
Amgen Inc cinacalcet hydrochloride 55513-073
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: TRIACETIN

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group